BIOMARKER:

AR-V7 positive

AR-V7 positive AR-V7 positive	Renal Cell Carcinoma RCC	abiraterone acetate Resistant: C3 – Early Trials
AR-V7 positive AR-V7 positive	Prostate Cancer Prostate Cancer	cabazitaxel Sensitive: C3 – Early Trials
AR-V7 positive AR-V7 positive	Prostate Cancer Prostate Cancer	docetaxel Sensitive: C3 – Early Trials
AR-V7 positive AR-V7 positive	Prostate Cancer Prostate Cancer	abiraterone acetate Resistant: C4 – Case Studies

Associations